CD183 (CXCR3) Antibody, anti-human, APC, REAfinity™ 130-120-450 from Miltenyi Biotec | Biocompare.com

Be the first to write a review!

Citations:

Supplier Page from
Miltenyi Biotec for
CD183 (CXCR3) Antibody, anti-human, APC, REAfinity™

The CD183 (CXCR3) Antibody, anti-human, APC, REAfinity™ from Miltenyi Biotec is a Human Monoclonal antibody to CXCR3. This antibody recognizes Human antigen. The CD183 (CXCR3) Antibody, anti-human, APC, REAfinity™ has been validated for the following applications: Staining, Fluorescence, Microscopy, Flow Cytometry, Immunocytochemistry, Immunofluorescence, and Immunohistochemistry.

Product Specs
ItemCD183 (CXCR3) Antibody, anti-human, APC, REAfinity™
CompanyMiltenyi Biotec
Price Pricing Info Supplier Page View Company Product Page
Catalog Number130-120-450
Quantity100 tests in 200 µL
ApplicationsFlow cytometry, MICS (MACSima Imaging Cyclic Staining), Immunofluorescence, Immunohistochemistry, Immunocytochemistry
Concentration1:50
Conjugate/TagAPC
FormatReagents are supplied in buffer containing stabilizer and 0.05% sodium azide
Reactivityhuman
IsotypeIgG1
CloneREA232
Hosthuman cell line
Antibody TypePrimary antibodies, Recombinant antibodies
Clonalitymonoclonal
TargetCD183 (CXCR3)
Research AreaFor research use only
Regulatory StatusFor research use only
NCBI Full Gene NameC-X-C motif chemokine receptor 3
NCBI Gene AliasesCD182, CD183, CKR-L2, CMKAR3, GPR9, IP10-R, Mig-R, MigR

Add to Compare List

Miltenyi Biotec

Local Office

Miltenyi Biotec

Miltenyi Biotec Inc.

2303 Lindbergh Street

Auburn, CA 95602

United States

Phone: Phone: +1 530 888 8871
Toll Free: 800 FOR MACS
Fax: +1 530 888 8925

Email: macs@miltenyibiotec.com

Company Profile

Website: www.miltenyibiotec.com

International Office

Miltenyi Biotec

Miltenyi Biotec B.V. & Co. KG

Friedrich-Ebert-Straße 68

51429 Bergisch Gladbach

Germany

Phone: +49 2204 8306-0
Fax: +49 2204 8306-235

Email: macs@miltenyibiotec.de

Company Profile

Website: www.miltenyibiotec.com

(1) Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell ActivationCancersApril 13, 2021Prat M, Salon M, Allain T, Dubreuil O, Noël G, Preisser L, Jean B, Cassard L, Lemée F, Tabah-Fish I, et al.FITC CD25-PE CD8-PEVio770 CD45-VioGreen Miltenyi Miltenyi Miltenyi Miltenyi Miltenyi Miltenyi Miltenyi Miltenyi 130-120-138 130-110-552 130-120-450 130-113-136 130-113-791 130-115-534 130-110-680 130-110-638 REA109 REA599 REA232 REA613 REA623 REA945 REA734 REA747 Experiment Regarding

(2) Identification of Immune Signatures of Novel Adjuvant Formulations Using Machine LearningScientific reportsNovember 30, 2018Chaudhury S, Duncan EH, Atre T, Storme CK, Beck K, Kaba SA, Lanar DE, Bergmann-Leitner ES.

(3) Circulating follicular T helper cells and cytokine profile in humans following vaccination with the rVSV-ZEBOV Ebola vaccineScientific reportsJune 21, 2016Farooq F, Beck K, Paolino KM, Phillips R, Waters NC, Regules JA, Bergmann-Leitner ES.

(4) Expression of chemokine receptor CXCR3 on T cells affects the balance between effector and memory CD8 T-cell generationProceedings of the National Academy of Sciences of the United States of AmericaMay 24, 2011Hu JK, Kagari T, Clingan JM, Matloubian M.

(5) Intracellular domains of CXCR3 that mediate CXCL9, CXCL10, and CXCL11 functionThe Journal of biological chemistryJuly 16, 2004Colvin RA, Campanella GS, Sun J, Luster AD.

Be the First to Write a Review!